Get 50% OFF This Summer!

Advertisement
logo

Titan Biotech

524717
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Titan Biotech Share price and Fundamental Analysis

View All Details
View All Details
Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities.
Company Incorporation1992
ChairmanNA
Head QuartersNew Delhi
Previous NameNA

Key Metrics

Market Cap (Cr)
395.13
PE Ratio
17.58
Industry P/E
32.05
PEG Ratio
-1.87
ROE
17.43%
ROCE
21.5%
ROA
11.17%
Total Debt (Cr)
2.61
Debt to Equity
0.02
Dividend Yield
0.42%
EPS
27.2
Book Value & P/B
175.44 x 2.73
Face Value
10
Outstanding Shares(Cr)
0.83
Current Ratio
4.06
EV to Sales
2.41

Stock Returns

1 Week+8.64%
1 Month-3.57%
6 Months-38.38%
1 Year-5.14%
3 Years+95.57%
5 Years+496.28%

CAGR

1 Year CAGR

Revenue Growth

+13.94%

Net Profit Growth

+12.55%

Operating Profit Growth

+14.52%

Dividend Growth

+11.11%

Stock Returns CAGR

-4.47%
no_data

No Stocks

Smart Score

2.5
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 55.88%

FIIs : 0.00%

DIIs : 0.01%

Public : 44.11%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
DII Shareholding Increased by 0.01% to 0.01% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Titan Biotech Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Titan Biotech Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities.

The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals souced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

During 2006-07, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 2009-10.

Titan Biotech Share Price

Titan Biotech share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Titan Biotech Market Cap

Market capitalization of Titan Biotech indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Titan Biotech is valued compared to its competitors.

Titan Biotech PE Ratio

Titan Biotech PE ratio helps investors understand what is the market value of each stock compared to Titan Biotech 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Titan Biotech PEG Ratio

The PEG ratio of Titan Biotech evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Titan Biotech ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Titan Biotech generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Titan Biotech ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Titan Biotech in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Titan Biotech Total Debt

Total debt of Titan Biotech shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Titan Biotech Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Titan Biotech compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Titan Biotech CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Titan Biotech over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Titan Biotech Technical Analysis

Technical analysis of Titan Biotech helps investors get an insight into when they can enter or exit the stock. Key components of Titan Biotech Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Titan Biotech shares often struggle to rise above due to selling pressure.

Titan Biotech Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Titan Biotech ’s financial health and profitability.

Titan Biotech Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Titan Biotech Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Titan Biotech Financials

The financials of Titan Biotech provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Titan Biotech Profit and Loss Statements

The profit and loss statement of Titan Biotech highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Titan Biotech .

Titan Biotech Balance Sheet

The balance sheet presents a snapshot of Titan Biotech ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Titan Biotech Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App